DMT310-001 Topical in the Treatment of Acne Vulgaris
Public ClinicalTrials.gov record NCT03536637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris
Study identification
- NCT ID
- NCT03536637
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Dermata Therapeutics
- Industry
- Enrollment
- 121 participants
Conditions and interventions
Conditions
Interventions
- DMT310 Drug
- Hydrogen Peroxide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 21, 2018
- Primary completion
- Dec 29, 2018
- Completion
- Jan 27, 2019
- Last update posted
- Jul 21, 2020
2018 – 2019
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermata Investigational Site | San Diego | California | 92123 | — |
| Dermata Investigational Site | Saint Joseph | Missouri | 64506 | — |
| Dermata Investigational Site | Henderson | Nevada | 89148 | — |
| Dermata Investigational Site | Albuquerque | New Mexico | 87106 | — |
| Dermata Investigational Site | High Point | North Carolina | 27262 | — |
| Dermata Investigational Site | Tennessee City | Tennessee | 37215 | — |
| Dermata Investigational Site | Austin | Texas | 78759 | — |
| Dermata Investigational Site | College Station | Texas | 77802 | — |
| Dermata Investigational Site | Katy | Texas | 77494 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03536637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03536637 live on ClinicalTrials.gov.